Clinical Trial: A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661329) titled 'A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study' on June 16.

Brief Summary: This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN(R) (bimatoprost ophthalmic solution) 0.01% of AbbVie INC in subjects with primary open angle glaucoma (POAG) or ocular hypertension.

Study Start Date: June 02

Study Type: INTERVENTIONAL

Condition: Primary Open Angle Glaucoma (POAG) Ocular Hypertension (OH)

Intervention: DRUG: Bimatoprost ophthalmic solution 0.0...